• Media Centre
  • Investor relations
  • Client area
  • Client area
  • Stewardship policy
  • Annual reports service

Form of Proxy

WUXI BIOLOGICS (CAYMAN) INC.

Notes

No. Proposition For Against Abstain
1

TO RECEIVE THE AUDITED CONSOLIDATED FINANCIAL STATEMENTS OF THE COMPANY AND ITS SUBSIDIARIES AND THE REPORTS OF THE DIRECTORS OF THE COMPANY ("DIRECTOR(S)") AND OF THE INDEPENDENT AUDITOR OF THE COMPANY FOR THE YEAR ENDED DECEMBER 31, 2025

2

TO RE-ELECT "DR. GE LI" AS NON-EXECUTIVE DIRECTOR

3

TO RE-ELECT "MR. KENNETH WALTON HITCHNER III" AS INDEPENDENT NON-EXECUTIVE DIRECTOR

4

TO RE-ELECT "DR. JUE CHEN" AS INDEPENDENT NON-EXECUTIVE DIRECTOR

5

TO AUTHORIZE THE BOARD OF DIRECTORS OR ANY DULY AUTHORIZED BOARD COMMITTEE TO FIX THE DIRECTORS' REMUNERATION FOR THE YEAR ENDING DECEMBER 31, 2026

6

TO RE-APPOINT MESSRS. DELOITTE TOUCHE TOHMATSU AS AUDITORS AND TO AUTHORIZE THE BOARD OF DIRECTORS OR ANY DULY AUTHORIZED BOARD COMMITTEE TO FIX THEIR REMUNERATION

7

TO GRANT A GENERAL MANDATE TO THE DIRECTORS TO ISSUE, ALLOT AND DEAL WITH THE SHARES OF THE COMPANY (INCLUDING ANY SALE OR TRANSFER OF TREASURY SHARES)

8

TO GRANT A GENERAL MANDATE TO THE DIRECTORS TO REPURCHASE THE SHARES OF THE COMPANY